Aspect Biosystems

Vancouver, Canada Founded: 2013 • Age: 13 yrs
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.

About Aspect Biosystems

Aspect Biosystems is a Technology company based in Vancouver (Canada) founded in 2013 by Simon Beyer, Tamer Mohamed, Sam Wadsworth, and Konrad Walus. Bioprinting technology and tissue therapeutics for regenerative medicine are developed. Aspect Biosystems has raised $138.68 million across 5 funding rounds from investors including Novo Nordisk, Innovate BC and Canadian Space Agency. Its chief executive, as recorded, is Tamer Mohamed. Its website aspectbiosystems.com draws about 18 thousand monthly visits. Aspect Biosystems offers products and services including Bioprinting Technology Platform. Its focus areas include High Tech, 3D Printing, Hardware and 3D Printers. Its legal entity is ASPECT BIOSYSTEMS LTD.

Company details

Aspect Biosystems was founded in 2013 in Vancouver, Canada. Bioprinting technology and tissue therapeutics are developed within the regenerative medicine sector. The platform is integrated with computational design, therapeutic cells, and biomaterials to produce implantable tissues. These tissues are designed to replace, repair, or supplement biological functions, particularly for metabolic and endocrine diseases. Collaborations with other organizations are maintained to advance operations.

  • Headquarters Vancouver, Canada
  • Founders Simon Beyer, Tamer Mohamed, Sam Wadsworth, Konrad Walus
  • Sectors
    Technology
  • Website aspectbiosystems.com
  • Social LinkedIn X YouTube
  • Legal Name Aspect Biosystems Ltd.
Key Metrics
  • Total Equity Funding
    $138.68M (USD)

    in 5 rounds

  • Latest Funding Round
    $115M (USD), Series B

    Jan 2025

  • Investors

Products & Services of Aspect Biosystems

Aspect Biosystems offers a comprehensive portfolio of products and services, including Bioprinting Technology Platform.

Bioprinting Technology Platform
Regenerative Medicine Tool

AI-powered system for creating implantable tissues to treat diseases.

Apps and channels of Aspect Biosystems

its YouTube channel Aspect Biosystems has 647 subscribers and 2 videos.

Aspect Biosystems
YouTube 647 subscribers 2 videos Science & Technology
Open channel

Videos from Aspect Biosystems

The most watched videos on Aspect Biosystems's YouTube channel, Aspect Biosystems (647 subscribers). Click a video to play it here.

Aspect Biosystems: The Bioprinting Process
81.2K views
Aspect Biosystems: Creating Meaningful Impact
3.2K views

More on Aspect Biosystems.

Funding Insights of Aspect Biosystems

Aspect Biosystems has successfully raised a total of $138.68M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $115 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $138.68M
  • Total Rounds 5
  • Last Round Series B β€” $115M
  • Investors Count 12

All 5 funding rounds of Aspect Biosystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2025$115MSeries B–Dimension
Jan 2020$19.98MSeries A–Radical Ventures
Nov 2018$2.7MSeries A––
May 2018$1MSeries A––
Sep 2017Series A–Pangaea Ventures
Valuation history

12 investors in total: 12 institutional.

Investors in Aspect Biosystems

Aspect Biosystems has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Novo Nordisk, Innovate BC and Canadian Space Agency.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Dimension is focused on investments at the intersection of technology and life sciences.
dimensioncap.com
Early-stage sector agnostic VC firm investing primarily in the US and Canada
pallasiteventures.comVancouver, Canada
Companies developing T1D products are funded through venture philanthropy.
t1dfund.orgBoston, United States
Startup accelerator firm backed by the British Columbia Government
2004innovatebc.caVancouver, Canada
Early-stage venture capital funding is provided by Rhino Ventures.
rhinovc.comVancouver, Canada
Venture capital firm focused on AI-driven companies
radical.vcToronto, Canada
Investment in hard tech for planetary health, focusing on materials science, chemistry, and biology.
pangaeaventures.com
Early-stage investments are made in tech and offline companies.
endurecap.comPalo Alto, United States
Relentless Venture Fund is focused on health technology investments.
relentlesspursuitpartners.comVancouver, Canada
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
1923novonordisk.comBagsvaerd, Denmark
Premium access

Investor details for Aspect Biosystems

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Aspect Biosystems

65 people are tracked at Aspect Biosystems (12 in leadership, 12 in board & advisors, 41 in team).

NameRoleGroup
Simon Beyer
Co-Founder & CTOLeadership
Tamer Mohamed
Co-Founder & CEOLeadership
Sam Wadsworth
Co-Founder & CSOLeadership
Konrad Walus
Co-FounderLeadership
Nicole Swanson
Executive Assistant To Chief Executive OfficerLeadership
Natalie Korenic
Chief Of Staff To The CEO & Sr. Director, CommunicationsLeadership
Lin-P'Ing Choo-Smith
Director, Preclinical ProgramsLeadership
Ray Smith
CFOLeadership
Amanda Fox
Director, TalentLeadership
Lloyd MacKenzie
Chief Technical Operations OfficerLeadership
Claire Cahill
Director, ContractsLeadership
Reza Jalili
Director, In Vivo SciencesLeadership
Don Haut
Board MemberBoard & advisors
Andrew Booth
AdvisorBoard & advisors
Kamran Alam
AdvisorBoard & advisors
Anil Dhawan
Scientific AdvisorBoard & advisors
Andrew Haughian
Board MemberBoard & advisors
Salim Teja
Board MemberBoard & advisors
James Shapiro
Scientific AdvisorBoard & advisors
Jane Lebkowski
Scientific AdvisorBoard & advisors

45 more people are available in the full profile.

Premium access

Complete people profiles for Aspect Biosystems

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Aspect Biosystems

3 dated milestones of Aspect Biosystems across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aspect Biosystems is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B, of $115.0M.

Web traffic of Aspect Biosystems

The website of Aspect Biosystems (aspectbiosystems.com) receives about 17.8K visits a month.

  • Monthly visits
    17.8K

    ▲ 166.8% vs previous month

Similar websites

Websites whose visitors overlap most with Aspect Biosystems. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abcellera.com
100%
29.9K#868,912View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aspect Biosystems

Premium access

Complete news archive for Aspect Biosystems

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aspect Biosystems

Aspect Biosystems was founded in 2013 and raised its 1st funding round 4 years after it was founded.

Aspect Biosystems is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.

Tamer Mohamed is the CEO of Aspect Biosystems, as recorded in our data. They have also founded this company.

Aspect Biosystems is a funded company, having raised a total of $138.68M across 5 funding rounds to date.

Aspect Biosystems was founded in 2013 in Vancouver, Canada. Bioprinting technology and tissue therapeutics are developed within the regenerative medicine sector. The platform is integrated with computational design, therapeutic cells, and biomaterials to produce implantable tissues. These tissues are designed to replace, repair, or supplement biological functions, particularly for metabolic and endocrine diseases. Collaborations with other organizations are maintained to advance operations.

Aspect Biosystems offers Bioprinting Technology Platform.

Aspect Biosystems has 12 investors. Key investors include Novo Nordisk, Innovate BC, Canadian Space Agency, Dimension, and Pallasite Ventures.

Aspect Biosystems operates through Aspect Biosystems Ltd..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available